Schweizer, Michael T <br/><br/>
A Phase I Study to Assess the Safety and Cancer-Homing Ability of Allogeneic Bone Marrow-Derived Mesenchymal Stem Cells in Men with Localized Prostate Cancer.  [electronic resource] 

 -  Stem cells translational medicine  05 2019 
 - 441-449 p.  digital 
<br/><br/> Publication Type: Clinical Trial, Phase I; Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't; Research Support, U.S. Gov't, Non-P.H.S. 
<br/><br/><label>ISSN: </label>2157-6580 
<br/><br/><label>Standard No.: </label>10.1002/sctm.18-0230  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adolescent<br/>Adult<br/>Animals<br/>Humans<br/>Male<br/>Mesenchymal Stem Cell Transplantation--methods<br/>Mesenchymal Stem Cells--metabolism<br/>Middle Aged<br/>Prostatic Neoplasms--physiopathology<br/>Quality of Life--psychology<br/>Transplantation, Homologous--methods<br/>Young Adult